Skip to main content
Log in

Stereoselective binding of tertatolol and of 4-hydroxytertatolol to human plasma proteins

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The binding of racemic tertatolol and 4-hydroxytertatolol and of their enantiomers was compared in α1-acid glycoprotein and albumin solutions. The binding rate of S(-)tertatolol to α1-acid glycoprotein was much greater than that of R(+)tertatolol, the binding of the racemate being intermediate. It was the reverse for the binding to albumin, although the differences were slight. The binding of 4-hydroxytertatolol racemate and enantiomers was very low as compared to the binding of tertatolol, and there were no statistically significant differences in the binding of the 4-hydroxytertatolol enantiomers to either α1-acid glycoprotein or albumin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Leeamn M., Naeije R., Degaute J.P., Brackman F., Thomas J. Prost J.F. (1986): Tertatolol preserves renal perfusion in patients with arterial hypertension after head injury. Am. J. Nephrol., 6 (Suppl. 2), 36–39.

    Article  Google Scholar 

  2. Smits J.F.M., Zeegers H.H.M. Struyker-Boudier H.A.J. (1989): Stereospecificity of α-adrenoceptor blockade and renal vasodilatation by tertatolol. Arch. Int. Pharmacodyn., 298, 164–171.

    PubMed  CAS  Google Scholar 

  3. Urien S., Morin D., Renouard A., Rocher I. Tillement J.P. (1988): Variations in serum binding of tertatolol mediated by disease-induced modification of α1-acid glycoprotein concentration. Eur. J. Clin. Pharmacol., 34, 381–385.

    Article  PubMed  CAS  Google Scholar 

  4. Glasson S., Zini R. Tillement J.P. (1982): Multiple serum binding of two thienopyridinic derivatives, ticlopidine and PCR 2362, and their distribution between HSA, α1-acid glycoprotein and lipoproteins. Biochem. Pharmacol., 31, 831–835.

    Article  PubMed  CAS  Google Scholar 

  5. Urien S., Riant P., Renouard A., Coulomb B., Rocher I. Tillement J.P. (1988): Binding of indapamide to serum proteins and erythrocytes. Biochem. Pharmacol., 37, 2963–2966.

    Article  PubMed  CAS  Google Scholar 

  6. Walle U.K, Walle T., Bai S.A. Olanoff F.S. (1983): Stereoselective binding of propranolol to human plasma, α1-acid glycoprotein, and albumin. Clin. Pharmacol. Ther., 34, 718–723.

    Article  PubMed  CAS  Google Scholar 

  7. Albani F., Riva R., Contin M. Baruzzi A. (1984): Stereoselective binding of propranolol enantiomers to human α1-acid glycoprotein and human plasma. Br. J. Clin. Pharmacol., 18, 244–246.

    PubMed  CAS  Google Scholar 

  8. Lima J J, Jungbluth G.L, Devine T. Robertson L.W. (1984): Stereoselective binding of disopyramide to human plasma protein. Life Sci, 35, 835–839.

    Article  PubMed  CAS  Google Scholar 

  9. Brunner F. Müller W.E. (1987): The stereoselectivity of the single drug binding site of human α-acid glycoprotein (orosomucoid). J. Pharm. Pharmacol, 39, 986–990.

    Article  PubMed  CAS  Google Scholar 

  10. Campbell D.B, Chignon J.C. Devissaguet J.P. (1986): Biodisposition of tertatolol in man: a review. Am. J. Nephrol., 6 (Suppl. 2), 61–68.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bastian, G., Urien, S., Brée, F. et al. Stereoselective binding of tertatolol and of 4-hydroxytertatolol to human plasma proteins. European Journal of Drug Metabolism and Pharmacokinetics 17, 233–236 (1992). https://doi.org/10.1007/BF03190151

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190151

Keywords

Navigation